Loading...
Successful treatment of atopic dermatitis with the JAK1 inhibitor oclacitinib
We report the first case of atopic dermatitis successfully treated with the oral Janus kinase-1 (JAK1) inhibitor oclacitinib. A man in his 70s, with a 6-year history of skin disease refractory to topical and biologic therapies, self-prescribed this veterinary medication with rapid remission of sympt...
Na minha lista:
| Udgivet i: | Proc (Bayl Univ Med Cent) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6413965/ https://ncbi.nlm.nih.gov/pubmed/30949000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2018.1480246 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|